⌘K
Loading ticker…
As of 2026-08-25, Bionano Genomics, Inc. Common Stock (BNGO) has a 3-month relative strength percentile of 54 within the TickerStance CS+ADRC universe (~5,000 tickers). Its Power rating (absolute 1–99) is 44. The current market Stance is 52.9 (Neutral). Sector: Healthcare, ranked 3 of 11. Average daily range 4.9%, relative volume 0.80×. TickerStance reports observed regime conditions across the full CS+ADRC universe; band assignment reflects current breadth, momentum, and macro inputs computed at the daily close. Percentile ranks run from 1 (weakest) to 99 (strongest) relative to all universe members on the same date.
Relative strength across horizons plus the leadership score.
Accumulation rating, relative volume, U/D ratio, breakout-day proof.
Diluted EPS, last 8 quarters. Loss makers are judged by progress toward breakeven.
BNGO appears in 1 ETF as of Mar 2026: VXF at 0.00% weight, $80K notional.
Held by 1 ETFs · $80K across latest filings · largest weight 0.00% (VXF).
Top 1 by value, from SEC N-PORT-P filings dated Mar 2026.
| ETF | Weight | Value | Δ |
|---|---|---|---|
| VXFVanguard Extended Market ETF | 0.00% | $80K | — |
As filed in N-PORT — quarterly holdings with up to ~60-day publication lag. Not live positioning.
Weak relative strength and quiet attention. Little to read here either way.
Measures how unusual this name’s public attention is against its own 90-day history — a surprise reading, not a ranking of how watched it is versus other stocks. Intel, not a signal.
Daily range, ATR, beta, and the math for a 1-ADR stop.
YoY sales growth, last 8 quarters. Sales must back the earnings story.
TTM operating margin. Expansion = real operating leverage.
YoY common shares outstanding. Down = buyback tailwind. Up > 2% = dilution flag.
Reported figures from SEC filings. No analyst estimates or forward guidance.
| Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | BNGO Jan avg: -24.66% median: -26.30% win: 25% σ: 39.50% n: 4 2022-04-12 → 2026-07-31 | BNGO Feb avg: -12.86% median: -15.69% win: 25% σ: 13.85% n: 4 2022-04-12 → 2026-07-31 | BNGO Mar avg: -14.89% median: -14.18% win: 25% σ: 14.39% n: 4 2022-04-12 → 2026-07-31 | BNGO Apr avg: -7.59% median: -20.44% win: 20% σ: 31.20% n: 5 2022-04-12 → 2026-07-31 | BNGO May avg: 3.04% median: 6.13% win: 80% σ: 7.00% n: 5 2022-04-12 → 2026-07-31 | BNGO Jun avg: -16.30% median: -11.84% win: 0% σ: 8.79% n: 5 2022-04-12 → 2026-07-31 | BNGO Jul avg: 2.43% median: -5.31% win: 20% σ: 18.16% n: 5 2022-04-12 → 2026-07-31 | BNGO Aug avg: 0.17% median: 0.83% win: 50% σ: 34.07% n: 4 2022-04-12 → 2026-07-31 (current) | BNGO Sep avg: -27.43% median: -23.86% win: 0% σ: 19.83% n: 4 2022-04-12 → 2026-07-31 | BNGO Oct avg: -14.37% median: -15.45% win: 50% σ: 37.64% n: 4 2022-04-12 → 2026-07-31 | BNGO Nov avg: -1.98% median: -4.51% win: 50% σ: 13.69% n: 4 2022-04-12 → 2026-07-31 | BNGO Dec avg: -3.24% median: -2.23% win: 50% σ: 22.56% n: 4 2022-04-12 → 2026-07-31 |